NCT01361737

Brief Summary

Could possible markers in serum obtained in the first trimester predict the human-pregnancy specific disorder pre-eclampsia?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jan 1999

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1999

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 1999

Completed
5.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2004

Completed
7.1 years until next milestone

First Submitted

Initial submission to the registry

May 25, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 27, 2011

Completed
Last Updated

July 6, 2011

Status Verified

May 1, 2011

Enrollment Period

Same day

First QC Date

May 25, 2011

Last Update Submit

July 3, 2011

Conditions

Preeclampsia

Keywords

Preeclampsiaserological bio-bankadiponectinsuPAR

Study Arms (1)

preeclampsia

* Control group: 86 healthy women not developing preeclampsia (PE) * Case group: 43 women developing PE

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Norwegian pregnant women

You may qualify if:

  • previous healthy

You may not qualify if:

  • Previous inflammatory diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital, Rikshospitalet

Oslo, 0027, Norway

Location

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 25, 2011

First Posted

May 27, 2011

Study Start

January 1, 1999

Primary Completion

January 1, 1999

Study Completion

May 1, 2004

Last Updated

July 6, 2011

Record last verified: 2011-05

Locations

NO(1)